SGS is investing €3.5 million in a two-phase expansion project at its lab in Poitiers, France, to implement a 50% increase in bioanalytical capabilities at the site by 2020.   The initial phase was completed in November 2018, with a new, 150 sq. meter immunoassay lab equipped with 8 instruments (MSD, ELISA, Luminex, Ella), along with the capacity to employ 20 analysts.   The second phase will include the construction of a new, 800 sq. meter building, housing both a new lab and office space, ...